Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00286728 · ClinicalTrials.gov registry record · NA
Dual Diagnosis Self-Help Referral
A NA study of Dual Diagnosis, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 287
- Enrollment target
- 1
- Study location
NCT00286728: Completed NA study of Dual Diagnosis, sponsored by VA Office of Research and Development.
NCT00286728 is a NA study of Dual Diagnosis that has completed, run by VA Office of Research and Development. The registered enrollment target is 287 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00286728, a NA study of Dual Diagnosis, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 287 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will help counselors in substance abuse treatment programs make effective referrals of dually diagnosed patients (those with a co-occurring psychiatric disorder) to self-help groups.
Primary Outcome
Addiction Severity Index psychiatric composite ranges from 0 to 1, with 1 indicating more severe problems.
Conditions Studied
Interventions
- BEHAVIORAL Intensive referral to dual-focused self-help
Study Locations (1)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 287 participants |
| Start Date | 2006-04 |
| Est. Completion | 2010-09 |
| Phase | NA |
What the finished NCT00286728 record still lists
NCT00286728 is an interventional study that assigns participants to a tested intervention. The registered 287 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Dual Diagnosis appearing as the primary indexed condition, and to 1 intervention - of which Intensive referral to dual-focused self-help is the first listed.
NCT00286728 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00286728 about?
NCT00286728 is a clinical study titled "Dual Diagnosis Self-Help Referral". This project will help counselors in substance abuse treatment programs make effective referrals of dually diagnosed patients (those with a co-occurring psychiatric disorder) to self-help groups.
What is the current status of trial NCT00286728?
This trial is currently completed. It is a NA study. The enrollment target is 287 participants. The study started on 2006-04. Estimated completion is 2010-09.
What conditions does trial NCT00286728 study?
This clinical trial studies the following conditions: Dual Diagnosis.
What interventions are being tested in trial NCT00286728?
The interventions under investigation include: Intensive referral to dual-focused self-help (BEHAVIORAL).
Who is sponsoring clinical trial NCT00286728?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00286728 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dual Diagnosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00286728's enrollment target sits among peer trials
287 377th of 2000 higher than 1,624 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03094429 · 287 participants · Phase 2
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
- NCT06385080 · 287 participants · Phase 1
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- NCT06919224 · 287 participants · NA
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia